BioCentury
ARTICLE | Company News

BioStratum, NephroGenex, Vanderbilt University deal

May 15, 2006 7:00 AM UTC

BioStratum granted NephroGenex U.S. and European rights to diabetic neuropathy compound Pyridorin pyridoxamine for an undisclosed amount of cash and stock. The deal also includes BioStratum's second-...